Global, regional, and national burden of NAFLD in youths and young adults aged 15–39 years, 1990–2021, its attributable risk factors, and projections to 2035: a systematic analysis of the Global Burden of Disease Study 2021 DOI Creative Commons
Jiong Wang,

Jiqing Du,

Minxiu Wang

et al.

Frontiers in Nutrition, Journal Year: 2025, Volume and Issue: 12

Published: Jan. 28, 2025

Non-alcoholic fatty liver disease (NAFLD) is a significant health burden in youths and young adults, the trend toward younger onset of NAFLD alarming. Utilizing data from Global Burden Disease (GBD) 2021 study, this study assessed trends adults aged 15–39 1990 to extracted on incidence, prevalence, death, disability-adjusted life-years (DALYs) rates NAFLD. We evaluated global temporal with estimated annual percentage change (EAPC) age-standardized rate (ASR). The Bayesian age-period-cohort (BAPC) model was used predict future 2035. found that has risen steadily 2021, projects increase 2035, which places enormous pressure society. To alleviate burden, implementing measures targeting risk factors such as glycemic control smoking cessation necessary.

Language: Английский

Current status and future trends of the global burden of MASLD DOI
Lei Miao, Giovanni Targher, Christopher D. Byrne

et al.

Trends in Endocrinology and Metabolism, Journal Year: 2024, Volume and Issue: 35(8), P. 697 - 707

Published: Feb. 29, 2024

Language: Английский

Citations

189

Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease DOI
Zobair M. Younossi, James M. Paik, Maria Stepanova

et al.

Journal of Hepatology, Journal Year: 2024, Volume and Issue: 80(5), P. 694 - 701

Published: Jan. 27, 2024

Language: Английский

Citations

137

The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes DOI
Zobair M. Younossi, Pegah Golabi, Jillian Kallman Price

et al.

Clinical Gastroenterology and Hepatology, Journal Year: 2024, Volume and Issue: 22(10), P. 1999 - 2010.e8

Published: March 21, 2024

Language: Английский

Citations

60

Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019 DOI
Pojsakorn Danpanichkul,

Kanokphong Suparan,

Priyata Dutta

et al.

Metabolism, Journal Year: 2024, Volume and Issue: 158, P. 155958 - 155958

Published: June 26, 2024

Language: Английский

Citations

28

Steatotic liver disease DOI
Mads Israelsen, Sven Francque, Emmanuel Tsochatzis

et al.

The Lancet, Journal Year: 2024, Volume and Issue: 404(10464), P. 1761 - 1778

Published: Nov. 1, 2024

Language: Английский

Citations

28

Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions DOI
Lung‐Yi Mak, Ken Liu, Sakkarin Chirapongsathorn

et al.

Nature Reviews Gastroenterology & Hepatology, Journal Year: 2024, Volume and Issue: 21(12), P. 834 - 851

Published: Aug. 15, 2024

Language: Английский

Citations

27

Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa DOI
Zobair M. Younossi, Pegah Golabi, James M. Paik

et al.

Liver International, Journal Year: 2024, Volume and Issue: 44(4), P. 1061 - 1070

Published: Feb. 2, 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty (NAFLD), is common and closely associated with type 2 diabetes (T2D). We assessed the prevalence of NAFLD/MASLD in general population among patients T2D Middle East North Africa (MENA) region.

Language: Английский

Citations

21

Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action DOI Open Access
Zobair M. Younossi, Linda Henry

Diabetes Spectrum, Journal Year: 2024, Volume and Issue: 37(1), P. 9 - 19

Published: Feb. 1, 2024

The prevalence of nonalcoholic fatty liver disease (NAFLD) in the United States is 38%, having increased by 50% within past 3 decades. estimated NAFLD among people with type 2 diabetes 55–70%. presence associated a higher likelihood progression to fibrosis development, transplant, and death. Cardiovascular main cause mortality NAFLD, risk death significantly both diabetes. carries high patient economic burdens but low awareness general public health care providers. This article reviews epidemiology discusses need for appropriate stratification, referral specialty care, management cardiometabolic factors, treatment disease. authors present call action raise address its increasing burden systematic efficient manner.

Language: Английский

Citations

19

Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction–Associated Fatty Liver Disease Among Adolescents in the United States DOI
James M. Paik,

Sandy Duong,

Shira Zelber‐Sagi

et al.

The American Journal of Gastroenterology, Journal Year: 2024, Volume and Issue: 119(6), P. 1089 - 1101

Published: March 13, 2024

INTRODUCTION: In the United States, 10.2% households (HH) report child food insecurity. We assessed associations between metabolic dysfunction–associated fatty liver disease (MASLD) and insecurity among adolescents in States. METHODS: This cross-sectional study was performed using data from National Health Nutrition Examination Survey 2017–2018. Food by US Department of Agriculture Child Security Module. MASLD defined transient elastography. RESULTS: Among 771 (aged 12–18 years) (mean age 14.7 years; 52.5% male; 50.9% White, 12.7% Black, 24.4% Hispanic, 12.1% other), 9.8% reported insecurity; prevalence 10.12% (95% confidence interval [CI] 7.13%–13.20%) affecting 4.27 million adolescents; nonalcoholic 10.77% CI 7.76–13.78) 4.52 adolescents. There near-perfect concordance (Cohen's κ coefficient 0.971, 95% 0.946–0.996). The greater food-insecure vs food-secure ones (17.4% 9.4%) living with a low HH income those higher (15.0% 7.2%) head lower education level one (18.0% 8.2%) ( P < 0.05). fully adjusted model showed that compared income, had 3-fold risk (odds ratio [OR] 3.25, 1.31–8.08) having MASLD, while low-income no increased (OR 1.58, 0.85–2.93, = 0.139). odds elevated +163% presence HTN 2.63, 1.02–6.78), +241% being Hispanic 3.41, 1.36–8.56), +138% male 2.38, 1.20–4.75). addition, 1-unit increase BMI associated 25% 1.25, 1.17–1.33) DISCUSSION: is especially individuals obesity hypertension. Policies addressing inequities are needed.

Language: Английский

Citations

17

Associations between estimated glucose disposal rate and arterial stiffness and mortality among US adults with non-alcoholic fatty liver disease DOI Creative Commons

Junting Song,

Ruicong Ma,

Lin Yin

et al.

Frontiers in Endocrinology, Journal Year: 2024, Volume and Issue: 15

Published: May 8, 2024

Background The estimated glucose disposal rate (eGDR), an effective indicator of insulin resistance, has been related to acute coronary syndrome, ischemic stroke and heart failure. This study aims explore the relationship between eGDR arterial stiffness, all-cause mortality cardiovascular in patients with non-alcoholic fatty liver disease (NAFLD). Methods Participants NAFLD were chosen from National Health Nutrition Examination Survey (NHANES) 1999 2018. main outcomes are stiffness (represented by pulse wave velocity, ePWV), mortality. Multiple cox regression models, restricted cubic spline, sensitivity analysis subgroup carried out investigate correlation resistance indicators stiffness. Furthermore, receiver operating characteristic curves used compare predictive value triglyceride-glucose (TyG) index homeostasis model assessment (HOMA-IR) for Results In this study, a total 4,861 participants included analysis. After adjusting confounding factors multivariate weighted model, was inversely associated (Q4 vs. Q1, HR =0.65 (0.48-0.89, P=0.01) =0.35 (0.19-0.65, P&lt;0.001). Compared TyG HOMA-IR, shows excellent (0.588 0.550 0.513, P &lt; 0.001) (0.625 0.553 0.537, 0.001). addition, we found significant negative (β=-0.13(-0.14–0.11, P&lt; However, HOMA-IR showed no Conclusions Low (an resistance) levels increased risk United States.

Language: Английский

Citations

14